Fabtech Technologies credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026
42.742.7
−176−176
0.10×0.10×
−0.42×−0.42×
1.22×1.22×
−6.99×−5.02×
7.14×7.14×
8.9%9.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FABTECH₹122.21

Fabtech Technologies Limited

· Pharma & Health
₹ CrorePeersLAXMIDENTLTARSONSFISCHERGKBMcap ₹543 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/09/2026
Total Debt42.742.7
Net Debt-175.6-175.6
Total Debt/Equity0.100.10
Net Debt/Equity-0.42-0.42
Total Debt/EBITDA1.221.22
Net Debt/EBITDA-5.02-6.99
Interest Coverage (EBIT/Interest)7.147.14
Total Debt/Total Capital %9.248.87
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.